INDIAN BENCHMARKS ends near day's highs led by IT shares
INDIAN BENCHMARKS surged in late
trades to end near their day's with IT majors leading the gains. Shares of Sun
Pharmaceutical gained by 2.5% after company has received approval from the US Food
and Drug Administration to sell a drug to treat Osteoporosis.
Further, Ranbaxy Labs ended up 3% that the
troubled drug major along with its rival Israeli Teva pharmaceutical are set to
settle a case in the United States alleging signing an unlawful agreement to
stall competition. Shares
of TechMahindra was up 15% and closed at Rs1843 on reports that Tech Mahindra,
Financial Technologies has come closer on deal talks.
The
crucial resistance for Nifty is now seen at 6190 and above this 6250.
Support for the immediate term is now placed at 6065 and next support
will be 5990.
0 Comments